| Literature DB >> 25041625 |
Lauren M Gardner1, David Rey, Anita E Heywood, Renin Toms, James Wood, S Travis Waller, C Raina MacIntyre.
Abstract
Between April 2012 and June 2014, 820 laboratory-confirmed cases of the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported in the Arabian Peninsula, Europe, North Africa, Southeast Asia, the Middle East, and the United States. The observed epidemiology is different to SARS, which showed a classic epidemic curve and was over in eight months. The much longer persistence of MERS-CoV in the population, with a lower reproductive number, some evidence of human-to-human transmission but an otherwise sporadic pattern, is difficult to explain. Using available epidemiological data, we implemented mathematical models to explore the transmission dynamics of MERS-CoV in the context of mass gatherings such as the Hajj pilgrimage, and found a discrepancy between the observed and expected epidemiology. The fact that no epidemic occurred in returning Hajj pilgrims in either 2012 or 2013 contradicts the long persistence of the virus in human populations. The explanations for this discrepancy include an ongoing, repeated nonhuman/sporadic source, a large proportion of undetected or unreported human-to-human cases, or a combination of the two. Furthermore, MERS-CoV is occurring in a region that is a major global transport hub and hosts significant mass gatherings, making it imperative to understand the source and means of the yet unexplained and puzzling ongoing persistence of the virus in the human population.Entities:
Keywords: Epidemiology; Hajj; MERS-CoV; mass gatherings; models
Mesh:
Year: 2014 PMID: 25041625 PMCID: PMC4238841 DOI: 10.1111/risa.12253
Source DB: PubMed Journal: Risk Anal ISSN: 0272-4332 Impact factor: 4.000
Figure 1(a) Comparison of the epidemiology of SARS and MERS‐CoV illustrated by epidemic curves from the date of the first case. (b) Epidemic curve summarizing temporal pattern of cases of MERS‐CoV, March 2012–June 2014 by month of onset.2
Figure 2Sensitivity analysis for probability of no secondary infection relative to probability of infection per contact. Analysis is based on 25 daily contacts.
Figure 3Sensitivity analysis for probability of no secondary infection relative to the group size for various probabilities of infection.
Figure 4Expected number of secondary infections in a group of size 1,000 for various contact rates and probability of infection. Results are based on a stochastic SEIR simulation model.